In plain language
In 70 patients undergoing bronchial artery embolization, a noise reduction imaging upgrade cut patient dose indices by about 60% with similar image quality. Staff dose was not measured, though lower patient dose generally means less scatter to the fluoroscopy team.
At a glance
- Type of study
- Original research, Retrospective cohort study
- Who was studied
- Patients
- Size
- n = 70 patients
- Summary based on
- the abstract
What it found
Dose area product fell by 59% after the noise reduction imaging upgrade.
Key figures: 149.2 (103.1-279.1) vs. 54.8 (38.2-100.7) Gy*cm2, p<0.001
Cumulative air kerma fell by 60% after the upgrade.
Key figures: 1.3 (0.6-1.9) vs. 0.5 (0.3-0.9) Gy, p<0.001
Image quality did not differ between groups.
Key figures: 3 (2,3) vs. 3 (2-4), p=0.64
Fluoroscopy time, exposure frames and contrast volume did not differ significantly.
Key figures: 28.8 vs. 28.1 min, p=0.73
Limits to keep in mind
Single-centre retrospective before-after comparison of 70 patients; only patient dose indices were measured, so any effect on staff dose is inferred rather than shown.
Related research summaries
- Fluoroscopy-minimization strategy for catheter ablation of Supraventricular Tachycardia by wOmen OPerators: the STOOP Multicentre Registry (2026, Prospective cohort study)
- Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
- Radiation Awareness for EVAR in Hybrid Operating Room: An Instant Operator Risk Chart (2021, Dosimetry measurement study)
- Utilization of a Radiation Safety Time-Out Reduces Radiation Exposure During Electrophysiology Procedures (2019, Prospective cohort study)
- Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia (2018, Case report or series)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.